India · Delayed Price · Currency is INR Lincoln Pharmaceuticals Statistics
Total Valuation
BOM:531633 has a market cap or net worth of INR 12.95 billion. The enterprise value is 10.58 billion.
| Market Cap | 12.95B |
| Enterprise Value | 10.58B |
Important Dates
The last earnings date was Thursday, May 28, 2026.
| Earnings Date | May 28, 2026 |
| Ex-Dividend Date | Sep 12, 2025 |
Share Statistics
BOM:531633 has 20.03 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 20.03M |
| Shares Outstanding | 20.03M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 48.07% |
| Owned by Institutions (%) | 2.07% |
| Float | 9.26M |
Valuation Ratios
The trailing PE ratio is 14.73.
| PE Ratio | 14.73 |
| Forward PE | n/a |
| PS Ratio | 1.93 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 1.71 |
| P/FCF Ratio | 16.00 |
| P/OCF Ratio | 12.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.83, with an EV/FCF ratio of 13.07.
| EV / Earnings | 12.04 |
| EV / Sales | 1.58 |
| EV / EBITDA | 10.83 |
| EV / EBIT | 12.72 |
| EV / FCF | 13.07 |
Financial Position
The company has a current ratio of 5.25, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.25 |
| Quick Ratio | 3.63 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.05 |
| Interest Coverage | 82.12 |
Financial Efficiency
Return on equity (ROE) is 12.30% and return on invested capital (ROIC) is 17.65%.
| Return on Equity (ROE) | 12.30% |
| Return on Assets (ROA) | 6.16% |
| Return on Invested Capital (ROIC) | 17.65% |
| Return on Capital Employed (ROCE) | 10.67% |
| Weighted Average Cost of Capital (WACC) | 6.24% |
| Revenue Per Employee | 3.62M |
| Profits Per Employee | 474,332 |
| Employee Count | 1,853 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 3.92 |
Taxes
In the past 12 months, BOM:531633 has paid 277.31 million in taxes.
| Income Tax | 277.31M |
| Effective Tax Rate | 23.98% |
Stock Price Statistics
The stock price has increased by +11.16% in the last 52 weeks. The beta is 0.35, so BOM:531633's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +11.16% |
| 50-Day Moving Average | 638.64 |
| 200-Day Moving Average | 558.64 |
| Relative Strength Index (RSI) | 50.82 |
| Average Volume (20 Days) | 7,943 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:531633 had revenue of INR 6.71 billion and earned 878.94 million in profits. Earnings per share was 43.88.
| Revenue | 6.71B |
| Gross Profit | 3.60B |
| Operating Income | 831.84M |
| Pretax Income | 1.16B |
| Net Income | 878.94M |
| EBITDA | 976.84M |
| EBIT | 831.84M |
| Earnings Per Share (EPS) | 43.88 |
Balance Sheet
The company has 2.41 billion in cash and 44.22 million in debt, with a net cash position of 2.37 billion or 118.21 per share.
| Cash & Cash Equivalents | 2.41B |
| Total Debt | 44.22M |
| Net Cash | 2.37B |
| Net Cash Per Share | 118.21 |
| Equity (Book Value) | 7.58B |
| Book Value Per Share | 378.34 |
| Working Capital | 4.72B |
Cash Flow
In the last 12 months, operating cash flow was 1.06 billion and capital expenditures -254.28 million, giving a free cash flow of 809.31 million.
| Operating Cash Flow | 1.06B |
| Capital Expenditures | -254.28M |
| Depreciation & Amortization | 145.00M |
| Net Borrowing | 44.22M |
| Free Cash Flow | 809.31M |
| FCF Per Share | 40.41 |
Margins
Gross margin is 53.63%, with operating and profit margins of 12.40% and 13.10%.
| Gross Margin | 53.63% |
| Operating Margin | 12.40% |
| Pretax Margin | 17.23% |
| Profit Margin | 13.10% |
| EBITDA Margin | 14.56% |
| EBIT Margin | 12.40% |
| FCF Margin | 12.06% |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 0.28%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 0.28% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 4.10% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 0.27% |
| Earnings Yield | 6.79% |
| FCF Yield | 6.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 19, 2009. It was a reverse split with a ratio of 0.2.
| Last Split Date | Mar 19, 2009 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |